Broad and defensible legal protections:

  • Significant IP portfolio in the US and internationally

Issued Patents:

  • 9,464,122 Methods and Compositions Comprising Tau Oligomers
  • 9,506,051 Tau protease compositions and methods of use
  • 9,650,436 Antibody based reagents that specifically recognize toxic oligomeric forms of tau
  • 10,465,001 Tau protease compositions and methods of use

Patents Pending – US, EU, Canada and Japan

  • Novel chemical matter, composition of matter, synthetic route, methods of use

Trademarks – One US trademark has issued (4,760,737), additional trademark filings are anticipated